A Conversation on Bridging Perspectives in Health Care
“Progress depends on the ability to engage with people whose perspectives differ from our own.” We recently spoke with Jennifer Mandel, a member of Reservoir’s Advocacy and Alliance Network, about what it means to communicate across differences — and how that plays out in health care. Jennifer has deep experience aligning different perspectives to advance health care, creating mutually beneficial partnerships with internal and external stakeholders and elevating organizational impact. This interview has […]
New CMMI Models, New Questions for Part D and Patients
Federal drug pricing policy is evolving at an extraordinary pace. With implementation of the Inflation Reduction Act (IRA) well underway and the recent announcements of new Center for Medicare and Medicaid Innovation (CMMI) models — GUARD and BALANCE to name a few — plans, manufacturers, providers and patients are navigating a rapidly shifting landscape. The volume and pace of change can be challenging to navigate. Read on for key implications, particularly for the […]
Immunology Beyond the Lab: Why Breakthrough Science Alone Isn’t Enough
Immunology is shaping one of the most dynamic areas of modern medicine. From autoimmune and inflammatory diseases – like atopic dermatitis, ulcerative colitis and Crohn’s disease – to oncology and rare conditions, the field is seeing sustained innovation as effective therapies enter the market and intensify competition. That’s because scientific breakthroughs are accelerating, pipelines are expanding and many emerging therapies are now designed to […]
Building Coalitions that Shape Smarter Health Care Legislation
Advancing health policies that improve outcomes and meet the moment requires careful leadership and collaboration. The journey from identifying an issue that needs to be addressed, to engaging with policy makers, to passing legislation takes significant time, energy and investment. Rarely can this work be carried forward by a single organization alone. Collaboration is essential. […]
Explaining Price in a Multi-Price World: What TrumpRx and Populist Pressure Mean for Pharma
For more than two decades, the dominant paradigm for explaining pharmaceutical pricing has been value. That value was defined by clinical benefit, improved patient outcomes or experience, and the longer-term societal return of reducing disease burden. While value itself has not had a singular definition, it did provide a framework that shaped how therapies were launched, reimbursed, and defended — particularly for specialty and […]
Are We at a Turning Point in Obesity Care?
November 2025 may ultimately be remembered as a pivotal moment in how the United States understands and treats obesity. Last month, federal regulators announced an effort to significantly expand coverage for obesity-management medications under Medicare – alongside a new pricing framework designed to lower costs for people paying out of pocket and potentially encouraging more […]
Health Care in an Election Year: A Survival Guide for Connecting with Voters in 2026
A new election cycle is upon us, which means America is once again scrolling its way through headlines, policy debates, and an endless stream of TikToks featuring people explaining complex health care issues from the front seat of their car. If you’re an organization in or around health care, you know what’s coming: a giant, […]
Empowering the Partners Who Expand Access to Care
Access to quality health care is something we all want. We all benefit from medical progress, innovative care and new technologies that help people live healthier lives. When people are healthy, families, communities and societies thrive. And while we know our health care system has real strengths, we also know it can be stronger — because right now, not everyone is getting the care they need. We […]
No Prescription Needed: The Big Switch Toward Patient Empowerment
America’s medicine cabinet hasn’t kept pace with its health care needs. While digital tools and consumer empowerment have transformed nearly every facet of modern health care, prescription-to-over-the-counter (Rx-to-OTC) product switches have slowed to a crawl. The FDA wants to change that. Flipping the Switch — Again The FDA is pushing to expand consumer access to […]
Value Communications in a Constantly Shifting Policy Landscape
Policy has always influenced how the biopharmaceutical industry communicates the value of its medicines. However, today’s value communicators must be more agile than ever. In the past two weeks alone, the White House has made announcements on TrumpRX, pricing deals with Pfizer and AstraZeneca, and delayed pharmaceutical tariffs—and this doesn’t account for ongoing policy around […]